65 A Long-term, Open-Label Study to Evaluate the Ability of Tenapanor (Alone or in Combination With Sevelamer) to Achieve Normal Serum Phosphorus in Patients With Chronic Kidney Disease on Dialysis (NORMALIZE) in Patients Treated for up to 2.5 Years